tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Fidia Boosts Share Capital After Convertible Bond Conversion

Story Highlights
Fidia Boosts Share Capital After Convertible Bond Conversion

Claim 70% Off TipRanks Premium

An update from Fidia Spa ( (IT:FDA) ) is now available.

Fidia has increased its fully paid‑up share capital to €9,847,761.90 following the conversion of €500,000 worth of outstanding convertible bonds into 5,000,000 new ordinary shares. As a result, the total number of ordinary shares admitted to trading on Euronext Milan has risen from 25,298,485 to 30,298,485, and the updated share capital structure has been duly filed with the Turin Companies Register, signalling a completed step in the company’s planned capital strengthening and a resulting dilution for existing shareholders but improved equity position for the group.

The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.15 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.

More about Fidia Spa

Fidia S.p.A., based in San Mauro Torinese and listed on Euronext Milan, is a global player in the design, production and marketing of high‑performance integrated milling systems. Its solutions, which include numerical controls, high‑speed milling machines and CAM software for complex shapes, are used mainly in the mould sector for the automotive industry and in the aerospace sector. With more than 50 years of experience and around 135 employees, the group is among the few industrial operators able to cover the entire milling process from programming to finished product.

YTD Price Performance: -96.65%

Average Trading Volume: 889,345

Technical Sentiment Signal: Strong Sell

Current Market Cap: €2.96M

For an in-depth examination of FDA stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1